New once-nightly pill may ease narcolepsy in kids
NCT ID NCT06809803
First seen Nov 06, 2025 · Last updated Jun 15, 2026 · Updated 29 times
Summary
This study tests a new extended-release sodium oxybate taken as a single dose at bedtime for children with narcolepsy type 1. The goal is to see if children prefer this once-nightly option over current twice-nightly oxybate medicines, and to check its safety and how well it controls symptoms like daytime sleepiness. About 36 children will take part at Stanford Sleep Clinic.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 1 (NT 1) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGRedwood City, California, 94063, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.